Structure of PDE3A-SLFN12 complex and structure-based design for a potent apoptosis inducer of tumor cells.
Structure of PDE3A-SLFN12 complex and structure-based design for a potent apoptosis inducer of tumor cells.
复制标题
DOI:
10.1038/s41467-021-26546-8
复制
发表时间:
2021-10-27
影响因子:
16.6
通讯作者:
Wang X
中科院分区:
文献类型:
--
作者:
Chen J;Liu N;Huang Y;Wang Y;Sun Y;Wu Q;Li D;Gao S;Wang HW;Huang N;Qi X;Wang X
Molecular glues are a class of small molecular drugs that mediate protein-protein interactions, that induce either the degradation or stabilization of target protein. A structurally diverse group of chemicals, including 17-β-estradiol (E2), anagrelide, nauclefine, and DNMDP, induces apoptosis by forming complexes with phosphodiesterase 3A (PDE3A) and Schlafen 12 protein (SLFN12). They do so by binding to the PDE3A enzymatic pocket that allows the compound-bound PDE3A to recruit and stabilize SLFN12, which in turn blocks protein translation, leading to apoptosis. In this work, we report the high-resolution cryo-electron microscopy structure of PDE3A-SLFN12 complexes isolated from cultured HeLa cells pre-treated with either anagrelide, or nauclefine, or DNMDP. The PDE3A-SLFN12 complexes exhibit a butterfly-like shape, forming a heterotetramer with these small molecules, which are packed in a shallow pocket in the catalytic domain of PDE3A. The resulting small molecule-modified interface binds to the short helix (E552-I558) of SLFN12 through hydrophobic interactions, thus “gluing” the two proteins together. Based on the complex structure, we designed and synthesized analogs of anagrelide, a known drug used for the treatment of thrombocytosis, to enhance their interactions with SLFN12, and achieved superior efficacy in inducing apoptosis in cultured cells as well as in tumor xenografts. Anagrelide, nauclefine and DNMDP induce apoptosis by forming complexes with phosphodiesterase 3A (PDE3A) and Schlafen 12 protein (SLFN12). Here, the authors present the cryo-EM structures of PDE3A-SLFN12 complexes with these compounds as molecular glues. Based on the complex structure, they developed an anagrelide analog that shows a higher potency in inducing apoptosis in cultured cells and also promotes tumor growth inhibition in tumor xenografts, which is of interest for cancer drug development.
登录
查看更多内容
DOI:
10.1107/s0907444904019158
发表时间:
2004-12-01
影响因子:
2.2
作者:
Emsley, P;Cowtan, K
通讯作者:
Cowtan, K
DOI:
10.1107/s2059798318006551
发表时间:
2018-06-01
期刊:
Acta crystallographica. Section D, Structural biology
影响因子:
--
作者:
Afonine PV;Poon BK;Read RJ;Sobolev OV;Terwilliger TC;Urzhumtsev A;Adams PD
通讯作者:
Adams PD
影响因子:
3
作者:
Pettersen, EF;Goddard, TD;Ferrin, TE
通讯作者:
Ferrin, TE
影响因子:
2.9
作者:
Pisareva, Vera P.;Muslimov, Ilham A.;Tcherepanov, Andrew;Pisarev, Andrey V.
通讯作者:
Pisarev, Andrey V.
DOI:
10.1016/j.bbrc.2008.03.032
发表时间:
2008-05-23
影响因子:
3.1
作者:
Neumann, Brent;Zhao, Liang;Gonda, Thomas J.
通讯作者:
Gonda, Thomas J.